COEP
Coeptis TherapeuticsยทNASDAQ
--
--(--)
--
--(--)
COEP Profile
Coeptis Therapeutics Holdings, Inc.
A biopharmaceutical company that developing innovative cell therapy platforms for cancer
Life Science Tools and Services
11/27/2018
12/17/2020
NASDAQ Stock Exchange
7
12-31
Common stock
105 Bradford Rd, Suite 420, Wexford, Pennsylvania 15090
--
Coeptis Therapeutics Holdings, Inc., was originally incorporated in the British Virgin Islands on November 27, 2018 and moved to Delaware on October 27, 2022. The company operates as a holding company and manages a series of subsidiaries focused on biopharmaceutical development. Its business model focuses on advancing the product portfolio through strategic cooperation, which may include authorized introduction, co-development and other collaborative arrangements in therapeutic areas such as oncology, respiratory virus infection and autoimmune diseases.
